Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...
Cellular senescence is an underlying mechanism of aging. Among older Americans, higher expression of genes linked to cellular senescence is seen in women and those with class II obesity, and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback